AG957

Overview

AG957 (Tyrphostin AG957;NSC 654705) is a tyrosine kinase inhibitor with anti- BCR/ABL tyrosine kinase activity. AG957 is a bcr/abl kinase inhibitor with an IC 50 of 2.9 μM for p210 bcr/abl autokinase activity.

Application

Products | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Parkinson's Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Bcr-Abl

Product Information

• Catalog No.: HY-117718
• CAS No.: 140674-76-6
• Molecular Formula: C15H15NO4
• Molecular Weight: 273.28
• Purity: 99.30%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (9.15 mM); Clear solution
• Availability: In-stock

Source

Original product source